Parameters of interferon system, matrix metalloproteinases and related tissue inhibitors in women with papillomavirus infection during preconceptional preparation
- 作者: Nevezhkina T.A.1, Knysh S.V.1, Chagina E.A.1, Matushkina L.S.1, Umerenkova S.A.1
-
隶属关系:
- Pacific State Medical University
- 期: 卷 23, 编号 3 (2020)
- 页面: 263-270
- 栏目: SHORT COMMUNICATIONS
- URL: https://ogarev-online.ru/1028-7221/article/view/119431
- DOI: https://doi.org/10.46235/1028-7221-334-POI
- ID: 119431
如何引用文章
全文:
详细
Pregravid or preconceptional preparation comprises one of important aspects in planing pregnancy and labor that includes a set of diagnostics as well as vurative and preventive measures aimed at ensuring conception and birth of healthy children. Currently, preconceptional preparation is viewed crucial for successful conception, both provided by a woman as well as a man. Virus-associated infection is one of the main causes resulting in impaired reproductive function. Host immune response in the urinary tract is often manifested as bacterial vaginosis (BV) underlying sufficient enviroinment for developing ascending inflammatory process that accounts for its intensity and duration and lead to reproductive disorders.
Our study provides the data on interferon system, matrix metalloproteinases and related tissue inhibitors in women with STDs and/or papillomavirus infection.
The aim of the study was to assess level of interferons, components of matrix metalloproteinases and related tissue inhibitors in women with papillomavirus infection during preconceptional preparation.
There were examined 73 patients for infection with sexually transmitted diseases (STDs) in accordance with standard protocol. All patients were divided into three groups: Group I (n = 32) – STDs with papillomavirus infection (PVI); Group II (n = 27) – STDs without papillomavirus infection and Group III – Control, consisting of 14 apparently healthy female volunteers. The average age of the patients and control subjects was 26.3±3.2 and 29.5±2.2 years, respectively. Blood serum IFN, MMP and TIMP levels were measured by using specific reagents (R&D Diagnostics Inc., USA) with sandwich ELISA, according to the manufacturer’s instructions, on Multiskan immunoassay analyzer (Finland), presented as pg/ml and ng/ml. SPSS v. 20 software was used for the statistical analysis with non-parametric method.
Disturbances in type 1, 2 and 3 interferons were found in women with papillomavirus infection. An increased amount of MMP-2,8,9 and related tissue inhibitors TIMP-1 and TIMP-3 in women with PVI was revealed. Long-term HPV persistence leads to developing chronic systemic inflammatory response manifested as immune-inflammatory syndrome accounting for tissue morphological changes making impossible onset of pregnancy.
作者简介
T. Nevezhkina
Pacific State Medical University
编辑信件的主要联系方式.
Email: www.tanya.ru9292@mail.ru
Nevezkina Tatyana A. - Assistant Professor, Normal and Pathological Physiology Department
690033, Vladivostok, 100 years Vladivostok ave., 62
Phone: 7 (914) 672-89-45
俄罗斯联邦S. Knysh
Pacific State Medical University
Email: fake@neicon.ru
Assistant Professor, Normal and Pathological Physiology Department
Vladivostok
俄罗斯联邦E. Chagina
Pacific State Medical University
Email: fake@neicon.ru
PhD (Medicine), Associate Professor, Assistant Professor, Normal and Pathological Physiology Department
Vladivostok
俄罗斯联邦L. Matushkina
Pacific State Medical University
Email: fake@neicon.ru
PhD (Medicine), Associate Professor, Head, Obstetrics and Gynecology Department
Vladivostok
俄罗斯联邦S. Umerenkova
Pacific State Medical University
Email: fake@neicon.ru
Student
Vladivostok
俄罗斯联邦参考
- Бахарева И.В. Cовременная прегравидарная подготовка: комплексный подход // РМЖ. Мать и дитя, 2017. № 12. С. 889-893. [Bakhareva I.V. Modern pregravid preparation: an integrated approach. RMZh. Mat i ditya = Russian Medical Journal. Mother and Baby, 2017, no. 12, pp. 889-893. (In Russ.)]
- Болатовна М.М., Ержанулы Р.А., Асалжанкызы Ш.А. Современные проблемы неразвивающейся беременности // Вестник Казахского национального медицинского университета, 2019. № 1. С. 26-28. [Bolatovna M.M., Erzhanuly R.A., Asylzhankyzy Sh.A. Modern problems of non-developing pregnancy. Vestnik Kazakhskogo matsionalnogo meditsinskogo universiteta = Bulletin of the Kazakh National Medical University, 2019, no. 1, pp. 26-28. (In Russ.)]
- Макацария А.Д., Бицадзе В.О., Хизроева Д.Х., Викулов Г.Х., Гомберг М.А. Эффективность и безопасность глюкозаминилмурамилдипептида в лечении заболеваний, ассоциированных с вирусом папилломы человека: систематический обзор // Акушерство, гинекология и репродукция, 2019. Т. 13, № 2. С. 132-153. [Makatsariya A.D., Bitsadze V.O., Khizroeva J.K., Vikulov G.K., Gomberg M.A., Khryanin A.A. Efficacy and safety of glucosaminylmuramyl dipeptide in treatment of human papillomavirus-associated diseases: a systematic review. Akusherstvo, ginekologiya i reproduktsiya = Obstetrics, Gynecology and Reproduction, 2019, Vol. 13, no. 2, pp. 132-153. (In Russ.)]
- Маркелова Е.В., Здор В.В., Романчук А.Л., Бирко О.Н. Матриксные металлопротеиназы их зависимость с системой цитокинов, диагностический и прогностический потенциал // Иммунопатология, аллергология, инфектология, 2016. № 2. С. 11-22. [Markelova E.V., Zdor V.V., Romanchuk A.L., Birko O.N. Matrix metalloproteinases: relationship with cytokines system, diagnostic and prognostic potential. Immunopatologiya, allergologiya, infektologiya = Immunopathology, Allergology, Infectology, 2016, no. 2, pp. 11-22. (In Russ.)]
- Посисеева Л.В. Коррекция инфекционных заболеваний в прегравидарной подготовке супружеских пар // Инфекционные болезни: новости, мнения, обучение, 2016. № 4. С. 131-134. [Posiseeva L.V. Correction of infectious diseases during pregravid preparation in couples. Infektsionnye bolezni: novosti, mneniya, obuchenie = Infectious Diseases: News, Opinions, Training, 2016, no. 4, pp. 131-134. (In Russ.)]
- Пустотина О.А. Прегравидарная подготовка // Медицинский совет, 2017. №. 13. С. 64-70. [Pustotina O.A. Preconception preparation. Meditsinskiy sovet = Medical Council, 2017, no. 13, pp. 64-70. (In Russ.)]
- Сабдулаева Э.Х., Оламова А.О., Бебнева Т.Н., Павлович С.В., Роговская С.И. Прегравидарная подготовка женщин с папилломавирусной инфекцией гениталий // Вестник Российского университета дружбы народов. Серия: Медицина, 2011. № 6. С. 152-159. [Sabdulaeva E.Kh., Olamova A.O., Bebneva T.N., Pavlovich S.V., Rogovskaya S.I. Pregravidal training for women with HPV infection of genitals. Vestnik Rossiyskogo universiteta druzhby narodov. Seriya: Meditsina = Bulletin of the Peoples’ Friendship University of Russia. Series: Medicine, 2011, no. 6, pp. 152-159. (In Russ.)]
- Тихомиров А.Л., Сарсания С.И., Филатова Г.А. Вирус папилломы человека: от понимания иммунопатогенеза к рациональной тактике ведения // Гинекология, 2018. № 20 (3). С. 5-11. [Tikhomirov A.L., Sarsaniya S.I., Filatova G.A. Human papilloma virus: from understanding of immunopathogenesis to rational tactics of management. Ginekologiya = Gynecology, 2018, no. 20 (3), pp. 5-11. (In Russ.)]
- Хохлова А.С., Маркелова Е.В., Филина Н.В., Овчинникова О.В., Ваева Т.Г., Кабиева А.А. Роль системы матриксных металлопротеиназ в прогрессировании первичной открытоугольной глаукомы // Тихоокеанский медицинский журнал, 2017. № 2. С. 32-34. [Khokhlova A.S., Markelova E.V., Filina N.V., Ovchinnikova O.V., Vaeva T.G., Kabieva A.A. The role of matrix metalloproteinase system in the primary open angle glaucoma patient. Tikhookeanskiy meditsinskiy zhurnal = Pacific Medical Journal, 2017, no. 2, pp. 32-34. (In Russ.)]
- Чертовских М.Н., Кулинич С.И. Оптимизация прегравидарной подготовки больных с неудачными программами ВРТ при бесплодии // Acta Biomedica Scientifica, 2013. № 2 (2). С. 83-86. [Chertovskih M.N., Kulinich S.I. Optimization of the pregravidal examination of patients with unsuccessful programs of assisted reproductive technology (patients with infertility). Acta Biomedica Scientifica, 2013, no. 2 (2), pp. 83-86.
- Lazear H.M., Nice T.J., Diamond M.S. Interferon-λ: immune functions at barrier surfaces and beyond. Immunity, 2015, Vol. 43, no. 1, pp. 15-28.
补充文件
